Eucrisa and Blepharitis - a phase IV clinical study of FDA data

Summary:

Blepharitis is reported as a side effect among people who take Eucrisa (crisaborole), especially for people who are female, 40-49 old, also take Tobradex, and have Dermatitis.

The phase IV clinical study analyzes which people have Blepharitis when taking Eucrisa. It is created by eHealthMe based on reports of 9,895 people who have side effects when taking Eucrisa from the FDA, and is updated regularly.

What is Eucrisa?

Eucrisa has active ingredients of crisaborole. eHealthMe is studying from 9,900 Eucrisa users. Check the latest studies of Eucrisa.

What is Blepharitis?

Blepharitis (chronic inflammation of the eyelid) is found to be associated with 512 drugs and 691 conditions by eHealthMe. Check the latest studies of Blepharitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

9,895 people reported to have side effects when taking Eucrisa.
Among them, 11 people (0.11%) have Blepharitis.

Among these 11 people:

What is the gender of people who have Blepharitis when taking Eucrisa? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Blepharitis when taking Eucrisa? *

What are other drugs people take besides Eucrisa? *

Dupixent: 2 people, 18.18%
Tobradex: 2 people, 18.18%
Zyrtec: 1 person, 9.09%
Hydrocortisone: 1 person, 9.09%
Magnesium: 1 person, 9.09%
Lotemax: 1 person, 9.09%
Lithium Carbonate: 1 person, 9.09%
Lidoderm: 1 person, 9.09%
Hydrocortisone Valerate: 1 person, 9.09%
Emgality: 1 person, 9.09%

What are other side effects people have besides Blepharitis? *

Application Site Pain: 4 people, 36.36%
Eyelid Irritation: 2 people, 18.18%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 18.18%
Eye Pain: 1 person, 9.09%
Burning Sensation: 1 person, 9.09%
Conjunctivitis (pink eye): 1 person, 9.09%
Dizziness: 1 person, 9.09%
Drug Ineffective: 1 person, 9.09%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 9.09%
Erythema Of Eyelid (redness of the eyelid): 1 person, 9.09%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 18.18%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 18.18%
Rashes (redness): 1 person, 9.09%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 9.09%
Multiple Allergies (allergy to multiple agents): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%
Eyelid Margin Crusting (crusting at the lid margins, generally worse on waking): 1 person, 9.09%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 9.09%
Dry Eyes (lack of adequate tears): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Eucrisa and have Blepharitis?

- Check whether Blepharitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eucrisa:

Eucrisa (9,900 reports)

Blepharitis treatments and more:

Blepharitis (5,399 reports)

Browse all side effects of Eucrisa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blepharitis:

Blepharitis (512 drugs)

Browse all the conditions that are associated with Blepharitis:

Blepharitis (691 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on crisaborole (the active ingredients of Eucrisa) and Eucrisa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.